EFPIA-EURORDIS joint statement published on patientaccess to medicines for rare diseases
The statement contains a series of proposals to improve the lives of people living with rare diseases by addressing access barriers to transformative medicines The EFPIA-EURORDIS joint statement on patient access to medicines for rare diseases across Europe has been published. The statement is based on an 18-month structured dialogue between the European…